Practice Management News

In a phase 2 clinical study, patients with advanced hepatocellular carcinoma displayed improved progression-free survival and time to progression survival rates after treatment with bavituximab and nexavar, according to data presented at the 2015 Society of Surgical Oncology Annual Cancer Symposium.

Early initiation of palliative care for patients with advanced cancer may not only improve their survival, but also reduce the depression and stress burden of family caregivers, according to results of two analyses of the ENABLE III trial.

The FDA has approved an additional indication for Evarrest, enabling the product to be used as an adjunct to hemostasis for controlling bleeding during adult liver surgery, according to a news release from the distributor.

Physicians working in hospitals with policies that reflect best-interest regarding do-not-resuscitate orders are comfortable suggesting against resuscitation, compared with physicians in hospitals that emphasized autonomy, according to data.

Quality of care indicators for decompensated cirrhosis were below standard levels among hospitalized patients at University of Vermont Medical Center, according to study data.

The American Society for Gastrointestinal Endoscopy held a meeting at which more than 60 experts and leaders in epidemiology, infection control, GI endoscopy and medical device design and safety convened to address best practices for prevention of antibiotic-resistant infections associated with endoscopic retrograde cholangiopancreatography, or ERCP, duodenoscopes, according to a press release.

Physicians appear to accept more new patients who are insured by Medicare or private insurance compared with Medicaid, according to a report by the CDC.

The rising costs of cancer drugs are detrimental to patient care and must be addressed, according to the authors of a special article published in Mayo Clinic Proceedings.

Sovaldi-based treatment regimens were most cost-effective for treatment-experienced patients with hepatitis C virus infection genotype 2 or 3 with cirrhosis, according to newly published data in Annals of Internal Medicine.

Treatment with Lantus reduced total liver fat burden for patients with type 2 diabetes, according to research published in Diabetes Care.